Shares of ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report) traded down 4.8% during trading on Wednesday . The company traded as low as $2.26 and last traded at $2.37. 1,397,673 shares changed hands during trading, an increase of 6,776% from the average session volume of 20,327 shares. The stock had previously closed at $2.49.
ImmunoPrecise Antibodies Price Performance
The company’s fifty day simple moving average is $1.90 and its 200 day simple moving average is $0.98.
ImmunoPrecise Antibodies Company Profile
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Featured Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- Differences Between Momentum Investing and Long Term Investing
- Back-to-School Shopping Hits $40B: 3 Retail Stocks to Watch Now
- Investing In Automotive Stocks
- Alphabet Stock Surges After Dodging Harsh Antitrust Remedies
- How to trade using analyst ratings
- Why Qualcomm Is Outperforming NVIDIA After Months of Lagging
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
